UPS Bets on Amazon, Despite Risk – The Wall Street Journal
While FedEx distances its self from Amazon, its biggest competitor is filling that gap. Amazon related revenue is 1.3% for FedEx while it is 10% at UPS.
Amazon may be working it’s way to competing in their market, there is still money to be made by both. The move to develop a network of local delivery companies may not work out, making the relationship with global shoppers more vital.
RECENT LAWSUITS IN MUSIC (WSJ)
Recent judgments against musicians, their labels, and producers make it more expensive to lack authentic creativity. Or at the very least requires the payment of a licensing fee to the person who owns the IP for the song, lyric, or musical element.
For decades, artists faced legal challenges from fellow artists for elements of their songs that are similar to theirs. Some claims appeared to be desperate money grabs, while others were deemed legitimate in eyes of a court. In the cases listed in the WSJ article, federal courts awarded over $8 million in damages where some legal minds felt the judgments went.
The appropriate path to avoid cost of litigation is to enter a royalties agreement before the song is released. Understandably, artists and production teams may not be able to identify every possible claim, but a proactive approach upfront can reduce a significant judgment later when the song is a hit.
Insurance Transparency (WSJ)
Transparency in cost can prove helpful to consumers. An important question to ask is whether informed consumers will have enough market power to drive down prices in the face of consolidation of health systems and private practices.
The effort to drive down consumer cost needs to include the elimination of unneeded services that do not impact health outcomes, but allow providers to charge additional fees. There could be cost savings in limiting or bundling charges for follow up appointments where patients do not actually receive care. This might help save patients some time and money at the same time, making the most of each visit to reduce the repeat visits.
The push to reduce prescription drug prices is important to reduce the gap between American and international buyers. But, the funding for research and development need to remain. Molecular drugs as well as biologics are not cheap to formulate, test, and market. But, consumers should receive fair prices, especially for life critical medications.
Pfizer to Merge Off-Patent Drug Business With Mylan – The Wall Street Journal.
Pfizer, a global leader in pharmaceuticals, continues its restructure. Pfizer followed the trend of ridding itself of its consumer health business not that long ago. Now, it will merge it’s off-patent product portfolio with Mylan in a new entity. It also recently acquired Array Biopharma.
WSJ: FOREIGN BUYERS OF HOMES DROP
Given the trade tension, not shocking investments in our housing market is decreasing. In many real estate markets, investments come from overseas investors seeking profits by flipping property.
In many large markets, real estate investments come from overseas from buyers who may never take residence in the property. Investments from Russian and Chinese moguls yield great returns for those flipping properties in quick moving markets. This helps revitalize areas and encourage investments in other ventures. In the face of trade tensions, a safer bet for investors might be to keep money at home until trade deals are finalized.
A problem occurring with the influx of real estate investments was displacement of residents no longer able to afford housing in the fast changing markets. While the only guarantee in life is change, there should be some consideration on how these communities are altered to allow for fair transitions. With the funds on the sidelines, residents need to identify whether their community is prime for revitalization and potentially position themselves to take advantage of the potential economic activity.